• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国公共部门早期临床研究中新统计方法的应用。

Uptake of novel statistical methods for early-phase clinical studies in the UK public sector.

机构信息

Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics, Lancaster University, Lancaster, UK.

出版信息

Clin Trials. 2013 Apr;10(2):344-6. doi: 10.1177/1740774512474375. Epub 2013 Feb 1.

DOI:10.1177/1740774512474375
PMID:23378484
Abstract

BACKGROUND

In recent years, the success rate of confirmatory studies has been poor resulting in more emphasis on the conduct of exploratory studies. As one possibility to improve decision-making during the early stages of development, adaptive and Bayesian methods have been recommended.

PURPOSE

To investigate the current practice in designing early-phase studies in UK public sector research institutions and the use of adaptive and Bayesian methods in particular and to determine factors that hinder the penetration of methodological advances into practice.

METHODS

A questionnaire was sent to all UK clinical trials units (CTUs) to gauge their involvement in early-phase studies and to learn about the designs used in these studies. Follow-up visits to units conducting early-phase studies with round-table discussions around the methods used and the obstacles faced when using adaptive methods were undertaken.

RESULTS

More than half of the CTUs are involved in early-phase studies, but conservatism in the methods used in these studies is present. Reasons for novel methodology not being used include a lack of expertise, incompatible funding and unit structure, and a lack of software.

LIMITATIONS

Information is collected from UK CTUs, which undertake a large portion (but not all) publicly funded trials.

CONCLUSIONS

The use of adaptive and Bayesian methods for early-phase clinical studies in the UK public sector is at present limited. Various different initiatives aim to support and facilitate the use of these methods, however, so that an increased use of these methods can be anticipated in the future.

摘要

背景

近年来,验证性研究的成功率一直很低,因此更加重视探索性研究的开展。作为一种改进开发早期决策的可能性,适应性和贝叶斯方法已被推荐使用。

目的

调查英国公共部门研究机构在设计早期阶段研究中的当前实践,特别是使用适应性和贝叶斯方法的情况,并确定阻碍方法学进展渗透到实践中的因素。

方法

向所有英国临床试验单位(CTU)发送了一份问卷,以评估他们在早期阶段研究中的参与情况,并了解这些研究中使用的设计。对正在进行早期阶段研究的单位进行了后续访问,围绕使用的方法进行了圆桌讨论,并探讨了在使用适应性方法时面临的障碍。

结果

超过一半的 CTU 参与了早期阶段的研究,但这些研究中使用的方法仍然比较保守。没有采用新方法的原因包括缺乏专业知识、资金和单位结构不兼容,以及缺乏软件。

局限性

信息是从英国 CTU 收集的,这些单位承担了大部分(但不是全部)公共资助的试验。

结论

目前,英国公共部门早期临床研究中使用适应性和贝叶斯方法的情况有限。各种不同的举措旨在支持和促进这些方法的使用,因此可以预期未来会更多地使用这些方法。

相似文献

1
Uptake of novel statistical methods for early-phase clinical studies in the UK public sector.英国公共部门早期临床研究中新统计方法的应用。
Clin Trials. 2013 Apr;10(2):344-6. doi: 10.1177/1740774512474375. Epub 2013 Feb 1.
2
Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials.跨部门调查评估关键利益相关者对确认性试验中适应性设计的适当使用的障碍、关注点和促进因素的看法。
Trials. 2015 Dec 23;16:585. doi: 10.1186/s13063-015-1119-x.
3
The impact of the 'Clinical Trials' directive on the cost and conduct of non-commercial cancer trials in the UK.“临床试验”指令对英国非商业性癌症试验成本及开展情况的影响。
Eur J Cancer. 2007 Jan;43(1):8-13. doi: 10.1016/j.ejca.2006.09.016. Epub 2006 Nov 21.
4
Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials.阶梯式试验中的缺失环节:一项关于关键利益相关者对确证性试验中适应性设计使用观点的定性研究
Trials. 2015 Sep 28;16:430. doi: 10.1186/s13063-015-0958-9.
5
Adaptive design of confirmatory trials: Advances and challenges.确证性试验的适应性设计:进展与挑战
Contemp Clin Trials. 2015 Nov;45(Pt A):93-102. doi: 10.1016/j.cct.2015.06.007. Epub 2015 Jun 14.
6
Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop.适应性设计概述、障碍及未来工作:来自 NIH 资助研讨会的观点。
Clin Trials. 2012 Dec;9(6):671-80. doi: 10.1177/1740774512461859.
7
UK publicly funded Clinical Trials Units supported a controlled access approach to share individual participant data but highlighted concerns.英国由公共资金资助的临床试验单位支持采用控制访问的方法来共享个体参与者数据,但也强调了一些担忧。
J Clin Epidemiol. 2016 Feb;70:17-25. doi: 10.1016/j.jclinepi.2015.07.002. Epub 2015 Jul 11.
8
Identifying research priorities for effective retention strategies in clinical trials.确定临床试验中有效保留策略的研究重点。
Trials. 2017 Aug 31;18(1):406. doi: 10.1186/s13063-017-2132-z.
9
Monitoring in practice - How are UK academic clinical trials monitored? A survey.实践中的监测 - 英国学术临床试验如何进行监测?一项调查。
Trials. 2020 Jan 9;21(1):59. doi: 10.1186/s13063-019-3976-1.
10
Using digital tools in the recruitment and retention in randomised controlled trials: survey of UK Clinical Trial Units and a qualitative study.在随机对照试验中使用数字工具进行招募和保留:对英国临床试验单位的调查和定性研究。
Trials. 2020 Apr 3;21(1):304. doi: 10.1186/s13063-020-04234-0.

引用本文的文献

1
Value-adaptive clinical trial designs for efficient delivery of publicly funded trials - a discussion of methods, case studies, opportunities and challenges.用于高效开展公共资助试验的价值适应性临床试验设计——方法、案例研究、机遇与挑战探讨
BMC Med Res Methodol. 2025 Jun 5;25(1):153. doi: 10.1186/s12874-025-02566-6.
2
Early phase clinical trials in oncology: Realising the potential of seamless designs.肿瘤学的早期临床试验:实现无缝设计的潜力。
Eur J Cancer. 2023 Aug;189:112916. doi: 10.1016/j.ejca.2023.05.005. Epub 2023 May 13.
3
SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol.
早期阶段剂量发现临床试验的 SPIRIT 和 CONSORT 扩展:DEFINE(剂量发现扩展)研究方案。
BMJ Open. 2023 Mar 29;13(3):e068173. doi: 10.1136/bmjopen-2022-068173.
4
Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs.实用临床试验中的分组序贯设计:利用近期多项外科 RCT 数据评估其可行性和实用性。
BMC Med Res Methodol. 2022 Oct 1;22(1):256. doi: 10.1186/s12874-022-01734-2.
5
Practical guidance for planning resources required to support publicly-funded adaptive clinical trials.支持公共资助的适应性临床试验所需资源规划的实用指南。
BMC Med. 2022 Aug 10;20(1):254. doi: 10.1186/s12916-022-02445-7.
6
Practical recommendations for implementing a Bayesian adaptive phase I design during a pandemic.大流行期间实施贝叶斯自适应 I 期设计的实用建议。
BMC Med Res Methodol. 2022 Jan 20;22(1):25. doi: 10.1186/s12874-022-01512-0.
7
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project.适应性临床试验的成本和人员资源需求:成本效益适应性临床试验项目的定量和定性结果。
BMC Med. 2021 Oct 26;19(1):251. doi: 10.1186/s12916-021-02124-z.
8
Would the Recommended Dose Have Been Different Using Novel Dose-Finding Designs? Comparing Dose-Finding Designs in Published Trials.采用新的剂量探索设计,推荐剂量会有所不同吗?比较已发表试验中的剂量探索设计。
JCO Precis Oncol. 2021 Jun 15;5. doi: 10.1200/PO.21.00136. eCollection 2021.
9
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.为临床试验设计增添灵活性:基于实例的适应性设计实际应用指南。
BMC Med. 2020 Nov 19;18(1):352. doi: 10.1186/s12916-020-01808-2.
10
Stakeholder perspectives on adaptive clinical trials: a scoping review.利益相关者对适应性临床试验的观点:范围综述。
Trials. 2020 Jun 17;21(1):539. doi: 10.1186/s13063-020-04466-0.